Skip to Content

IQVIA Holdings Inc IQV Stock Quote

| Rating as of


Last close prices updated as of Jun 05, 2023, 1:43 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 201.37
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Investment Style Mid Blend
  • Day Range 199.93  –  204.07
  • Year Range 165.75  –  249.11
  • Market Cap 37.7444 Bil
  • Volume / Avg 263,424.0 /  1.2 Mil
  • Price / Sales 2.63
  • Price / Book 6.30
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis IQV

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


IQVIA Earnings: Strong Outsourcing Demand Drives Revenue Growth; Shares Undervalued

Rachel Elfman Equity Analyst

Analyst Note

| Rachel Elfman |

Narrow-moat IQVIA reported solid first-quarter results highlighted by revenue over $3.6 billion, representing a 2.4% increase versus the prior year. Strong outsourcing demand continues to drive growth for IQVIA’s research and development solutions segment. We maintain our fair value estimate of $268 per share, and shares currently trade in 4-star territory about 30% below our fair value estimate.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics IQV

Company Profile IQV

Business Description

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The Technology & Analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

2400 Ellis Road
Durham, NC, 27703
Industry Diagnostics & Research
Employees 8,700

Related Articles IQV

Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of IQV’s competitive advantage.

IQVIA Holdings Inc


Charles River Laboratories International Inc


Icon PLC


Syneos Health Inc Class A

+$1.90 (0.94%) −$1.14 (0.57%) −$2.78 (1.26%) $0.00 (0.00%)
Market Cap
37.74 Bil10.23 Bil17.95 Bil4.31 Bil
Diagnostics & Research Diagnostics & Research Diagnostics & Research Diagnostics & Research

* Trading data in this section is delayed by at least 15 minutes.

FAQs for IQVIA Holdings Inc Stock

No. IQV does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

IQV’s market cap is 37.74 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

IQV’s stock style is Mid Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

IQV’s price/sales is 2.63.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

IQV’s price/forward earnings is 36.22.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

IQV’s price/book is 6.30.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See IQV’s valuation ratios compared to the Market Index.

IQV’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare IQV’s historical performance against its industry peers and the overall market.